PL3814533T3 - Sygnatury mikro-rna do przewidywania dysfunkcji wątroby - Google Patents

Sygnatury mikro-rna do przewidywania dysfunkcji wątroby

Info

Publication number
PL3814533T3
PL3814533T3 PL19773418T PL19773418T PL3814533T3 PL 3814533 T3 PL3814533 T3 PL 3814533T3 PL 19773418 T PL19773418 T PL 19773418T PL 19773418 T PL19773418 T PL 19773418T PL 3814533 T3 PL3814533 T3 PL 3814533T3
Authority
PL
Poland
Prior art keywords
prediction
micro
liver dysfunction
rna signatures
signatures
Prior art date
Application number
PL19773418T
Other languages
English (en)
Inventor
Matthias Hackl
Alice ASSINGER
Patrick STARLINGER
Original Assignee
Tamirna Gmbh
Medizinische Universität Wien
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tamirna Gmbh, Medizinische Universität Wien filed Critical Tamirna Gmbh
Publication of PL3814533T3 publication Critical patent/PL3814533T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL19773418T 2018-09-20 2019-09-20 Sygnatury mikro-rna do przewidywania dysfunkcji wątroby PL3814533T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT508042018 2018-09-20
EP19773418.9A EP3814533B1 (en) 2018-09-20 2019-09-20 Micro-rna signatures for the prediction of liver dysfunction
PCT/EP2019/075319 WO2020058472A1 (en) 2018-09-20 2019-09-20 Micro-rna signatures for the prediction of liver dysfunction

Publications (1)

Publication Number Publication Date
PL3814533T3 true PL3814533T3 (pl) 2022-01-31

Family

ID=68051797

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19773418T PL3814533T3 (pl) 2018-09-20 2019-09-20 Sygnatury mikro-rna do przewidywania dysfunkcji wątroby

Country Status (11)

Country Link
US (1) US11339440B2 (pl)
EP (1) EP3814533B1 (pl)
JP (1) JP7045527B2 (pl)
KR (1) KR102339206B1 (pl)
CN (1) CN112867802B (pl)
CA (1) CA3110668C (pl)
DK (1) DK3814533T3 (pl)
ES (1) ES2899203T3 (pl)
PL (1) PL3814533T3 (pl)
SG (1) SG11202101798QA (pl)
WO (1) WO2020058472A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI758670B (zh) * 2018-12-24 2022-03-21 奎克生技光電股份有限公司 健康風險評估方法
CN111363829B (zh) * 2020-05-27 2020-09-22 北京信诺卫康科技有限公司 胆管癌的miRNA标记物及其应用
WO2022183019A1 (en) * 2021-02-25 2022-09-01 Solasal Methods for mitigation of algorithmic bias discrimination, proxy discrimination and disparate impact
CN116110536A (zh) * 2023-02-20 2023-05-12 中国人民解放军空军军医大学 人工智能精准预测局限性肝癌患者选择治疗方案的方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69528706T2 (de) 1994-08-19 2003-06-12 Pe Corp. (Ny), Foster City Gekoppeltes ampflikation- und ligationverfahren
GB9626815D0 (en) 1996-12-23 1997-02-12 Cemu Bioteknik Ab Method of sequencing DNA
US6969488B2 (en) 1998-05-22 2005-11-29 Solexa, Inc. System and apparatus for sequential processing of analytes
AR021833A1 (es) 1998-09-30 2002-08-07 Applied Research Systems Metodos de amplificacion y secuenciacion de acido nucleico
US6818395B1 (en) 1999-06-28 2004-11-16 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
US7501245B2 (en) 1999-06-28 2009-03-10 Helicos Biosciences Corp. Methods and apparatuses for analyzing polynucleotide sequences
AU7537200A (en) 1999-09-29 2001-04-30 Solexa Ltd. Polynucleotide sequencing
ATE377093T1 (de) 2000-07-07 2007-11-15 Visigen Biotechnologies Inc Sequenzbestimmung in echtzeit
US7169560B2 (en) 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
CA2579150C (en) 2004-09-17 2014-11-25 Pacific Biosciences Of California, Inc. Apparatus and method for analysis of molecules
US7170050B2 (en) 2004-09-17 2007-01-30 Pacific Biosciences Of California, Inc. Apparatus and methods for optical analysis of molecules
US7482120B2 (en) 2005-01-28 2009-01-27 Helicos Biosciences Corporation Methods and compositions for improving fidelity in a nucleic acid synthesis reaction
WO2007073737A1 (en) * 2005-12-29 2007-07-05 Exiqon A/S Detection of tissue origin of cancer
US7282337B1 (en) 2006-04-14 2007-10-16 Helicos Biosciences Corporation Methods for increasing accuracy of nucleic acid sequencing
US10545149B2 (en) * 2008-10-06 2020-01-28 Morehouse School Of Medicine Detection of HIV-related proteins in urine
CN102985558B (zh) * 2008-11-13 2015-08-19 复旦大学 用于肝细胞癌症的微rna表达谱分析的组合物和方法
CN101418343A (zh) 2008-12-10 2009-04-29 复旦大学附属中山医院 miRNA在预测早期原发性肝癌病人术后复发的应用及其试剂盒
EP2196543A1 (en) * 2008-12-15 2010-06-16 Koninklijke Philips Electronics N.V. Compositions and methods for micro-rna expression profiling of hepatocellular cancer
WO2011014476A1 (en) 2009-07-30 2011-02-03 Ut-Battelle, Llc Composite nuclear fuel pellet
WO2011076141A1 (en) 2009-12-24 2011-06-30 Fudan University Diagnostic kits comprising microrna biomarkers and methods for diagnosis of hepatocellular cancer
CN102206642A (zh) * 2010-03-29 2011-10-05 北京大学 具有哺乳动物体液稳定性的双链rna分子及其制备和应用
SG10201503540QA (en) 2010-05-06 2015-06-29 Ibis Biosciences Inc Integrated sample preparation systems and stabilized enzyme mixtures
WO2012151212A1 (en) * 2011-05-01 2012-11-08 University Of Rochester Multifocal hepatocellular carcinoma microrna expression patterns and uses thereof
CN102776185B (zh) 2011-05-06 2013-07-10 复旦大学附属中山医院 由血浆microRNA组合成的肝癌诊断标志物及一种诊断肝癌的新方法
KR101532210B1 (ko) 2011-05-06 2015-06-29 중산 호스피탈 푸단 유니버시티 플라즈마 마크로알엔에이로 구성된 간암 진단 마커 및 간암 진단의 새로운 방법
US10155941B2 (en) 2012-08-01 2018-12-18 Bernhard Suter High throughput yeast two-hybrid screening method and reagent kit
TW201418472A (zh) * 2012-11-12 2014-05-16 Zhongshan Hospital Fudan Univ 由血漿microRNA組合成之肝癌診斷標誌物及診斷肝癌之新方法
EP2829613A1 (en) * 2013-07-26 2015-01-28 Istituto Nazionale Di Genetica Molecolare-INGM Biomarkers of liver diseases and uses thereof
PL405648A1 (pl) * 2013-10-15 2015-04-27 Warszawski Uniwersytet Medyczny Sposób diagnozowania raka watrobowokomórkowego, zastosowanie markera mikroRNA do diagnozowania zmiany chorobowej w obrębie wątroby, oceny stopnia zaawansowania choroby oraz oceny podatności pacjenta i/lub choroby na zaproponowane leczenie oraz zawierający takie markery zestaw diagnostyczny
KR102679577B1 (ko) * 2014-06-11 2024-07-01 국립연구개발법인 고쿠리츠간켄큐센터 담도암 검출 키트 또는 디바이스 및 검출 방법
BR112016029634A2 (pt) 2014-06-18 2017-10-24 Nat Cancer Ct kit, dispositivo e método para a detecção de câncer de fígado
US10801072B2 (en) 2014-09-04 2020-10-13 Miodx Method of analysis allowing avoidance of surgery
EP3663403A1 (en) 2014-09-26 2020-06-10 University of Massachusetts Rna-modulating agents
US10495648B2 (en) 2017-06-13 2019-12-03 Gilead Sciences, Inc. Methods of treating liver fibrosis

Also Published As

Publication number Publication date
CN112867802B (zh) 2024-06-04
CA3110668C (en) 2022-01-11
EP3814533A1 (en) 2021-05-05
KR20210057065A (ko) 2021-05-20
EP3814533B1 (en) 2021-08-11
CA3110668A1 (en) 2020-03-26
WO2020058472A1 (en) 2020-03-26
CN112867802A (zh) 2021-05-28
SG11202101798QA (en) 2021-04-29
US20210269882A1 (en) 2021-09-02
DK3814533T3 (da) 2021-11-15
JP7045527B2 (ja) 2022-03-31
JP2021527448A (ja) 2021-10-14
ES2899203T3 (es) 2022-03-10
KR102339206B1 (ko) 2021-12-14
US11339440B2 (en) 2022-05-24

Similar Documents

Publication Publication Date Title
GB2590844B (en) Simplified cross component prediction
SG11202103839UA (en) Substituted 6-azabenzimidazole compounds as hpk1 inhibitors
IL276346B (en) What he watched for maritime supervision
PL3827042T3 (pl) Związek wielo-azyrydynowy
SG11202101798QA (en) Micro-rna signatures for the prediction of liver dysfunction
GB201819126D0 (en) Inhibitor compounds
ZA202101671B (en) Imidazopyridinone compound
SG11202100267TA (en) Solid forms of an azolopyrimidine compound
IL275536A (en) Methods for quantification of polypeptides
SG11202105271PA (en) Improved self-tanning compositions
PT3790870T (pt) Compostos de ciclopentano
GB201902449D0 (en) Range prediction
IL276107A (en) Crystalline forms of psoorstam
SG11202007369QA (en) Deck plate
GB201819136D0 (en) Inhibitor compounds
GB2570453B (en) Floating deck assembly
SG11202006798QA (en) Zinc-binder based ebna1-specific compounds
IL282062A (en) Vinaigrette
GB2581532B (en) Flange anchor
GB201803836D0 (en) Improved flange
GB201806131D0 (en) Inhibitor compounds
GB201806130D0 (en) Inhibitor compounds
GB201806132D0 (en) Inhibitor coumpounds
AU201811824S (en) Kayak
AU2017902434A0 (en) Floating flange